Jan 11, 2026 GenomeWeb: Testing Growth Spurs Castle Biosciences Full-Year 2025 Preliminary Revenue Gain
Dec 17, 2025 Dermatology Times: DecisionDx-UM and PRAME Improve Metastatic Risk Prediction in Uveal Melanoma
Dec 16, 2025 Dermatology Times: Expert Panel Unanimously Backs DecisionDx-Melanoma for Guiding Personalized Cancer Care
Dec 16, 2025 BINJE (Business in New Jersey): Virtua Health Pioneers Use of TissueCypher to Personalize Esophageal Cancer Risk Assessment in New Jersey
Dec 5, 2025 The Dermatology Digest: Real-World Insights on Gene Expression Profile Testing in Melanoma
Dec 1, 2025 The Dermatology Digest: Advances in Skin Cancer Dectection: Applying Data on DecisionDx-SCC and DecisionDx-Melanoma into Clinical Practice
Nov 19, 2025 Dermatology Times: DecisionDx-Melanoma GEP Test Accurately Predicts SLN Positivity and Refines Recurrence Risk Assessment, New Data Shows
